Itau Unibanco Holding S.A.’s Revance Therapeutics, Inc. RVNC Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,563	Closed	-$20K	–	994
2019 Q3	$20K	Hold	1,563	–	–	﹤0.01%	265
2019 Q2	$20K	Sell	1,563 -274	-15%	-$3.45K	﹤0.01%	572
2019 Q1	$36K	Hold	1,837	–	–	﹤0.01%	549
2018 Q4	$36K	Buy	1,837 +69	+4%	+$1.52K	﹤0.01%	549
2018 Q3	$44K	Sell	1,768 -147	-8%	-$4K	﹤0.01%	551
2018 Q2	$52K	Sell	1,915 -273	-12%	-$8.21K	0.01%	617
2018 Q1	$67K	Buy	2,188 +1,310	+149%	+$42.1K	﹤0.01%	457
2017 Q4	$31K	Buy	878 +333	+61%	+$9.56K	﹤0.01%	464
2017 Q3	$48K	Buy	+545	New	+$13.2K	﹤0.01%	589

Other funds holding RVNC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Itau Unibanco Holding S.A.'s RVNC Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Revance Therapeutics, Inc. (RVNC) in Q4 2019, closing a stake of 1,563 shares — an estimated $20K sold.

Itau Unibanco Holding S.A. first reported a position in RVNC in Q3 2017 and held it in 9 quarters. The position peaked at $67K in Q1 2018. 134 funds tracked by Wall St. Rank hold RVNC as of Q4 2019.

Itau Unibanco Holding S.A. reported no remaining Revance Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 1,563 Revance Therapeutics, Inc. shares in Q4 2019, an estimated $20K.
Itau Unibanco Holding S.A. first reported a position in Revance Therapeutics, Inc. in Q3 2017 and held it in 9 quarters.
Itau Unibanco Holding S.A.'s Revance Therapeutics, Inc. position peaked at $67K in Q1 2018.
134 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.